glp 1 agonist mechanism of action weight loss of GLP-1 [25] Frontiers | Exploring the multifaceted

Furthermore, the FDA has issued warnings regarding mass-marketed, non-FDA-approved compounded GLP-1 alternatives

In fact, studies have revealed an inverse correlation between DPP-4 activity levels and BMD, suggesting a likely role of DPP-4 in bone homeostasis [5,6,7,8, 10]

GLP-1s are primarily for treating type 2 diabetes, obesity, cardiovascular disease, and sleep apnea

Patient education regarding potential vestibular symptoms is essential, as early recognition and reporting can facilitate prompt intervention

Pioglitazone and vitamin E can be considered with improvement in MASH and stabilization of fibrosis, as suggested by some studies (10, 11)